Krishna J. Rocha-Singh, MD, FACC

Technology Pulse

Catheter-Based Renal Denervation for Blood Pressure Reduction

06/04/2009

How does the renal sympathetic system help to regulate blood pressure? The sympathetic system fuels the release of certain hormones that are an augmenter to blood pressure. These hormones are typically used in the “fight or flight” type...

How does the renal sympathetic...

06/04/2009

Cath Lab Digest

Original Research

Acute Results of Directional Atherectomy for the Treatment of Claudication and Critical Limb Ischemia in the DEFINITIVE LE Study

02/08/2017

Krishna J. Rocha-Singh , MD, FACC;

Lawrence A. Garcia , MD, FACC, FAHA;

James F. McKinsey , MD;

Thomas Zeller , MD, PhD;

Michael R. Jaff , MD, DO;

This study assesses the acute safety of directional atherectomy for endovascular treatment of peripheral arterial disease in infrainguinal arteries.

This study assesses the acute...

02/08/2017

Vascular Disease Management

NACCME CME OFFERING

Free CME! Utilizing Directional Atherectomy to Treat Complex Lesions: A Case-Based and Data-Driven Webcast

05/25/2021

Krishna J. Rocha-Singh , MD, FACC;

Eric C. Scott , MD;

Ravish Sachar , MD, FACC;

This activity from the North American Center for Continuing Medical Education (NACCME) is designed for interventional cardiologists, vascular surgeons, interventional radiologists, nurses, PAs, and vascular and interventional techs.

This activity from the North...

05/25/2021

Cath Lab Digest

Review

Technical Considerations for Renal Artery Stenting

09/05/2008

Krishna J. Rocha-Singh , MD, FACC;

Jeffrey A. Goldstein , MD;

Raghu Kolluri , MS, MD, RVT, FSVM;

Renal artery stenosis is the most common secondary cause of hypertension. It affects 5% of the 50 million people with HTN in the United States. Renovascular disease leads to malignant HTN in 10–45% of patients.

Renal artery stenosis is the...

09/05/2008

Vascular Disease Management

Review

Endovascular Therapy for Treatment of Resistant Hypertension: Emerging Controversies and Technical Evolution

06/04/2013

Krishna J. Rocha-Singh , MD, FACC;

Despite encouraging early observations of renal denervation for treatment-resistant hypertension, recent reports in larger patient cohorts have suggested higher than initially reported nonresponder rates. Industry has responded with rapid...

Despite encouraging early...

06/04/2013

Vascular Disease Management